Companies / CMP
COMPUMEDICS LIMITED
ASX:CMPHealth Care Equipment & Services199.8M shares on issueASX (delayed) · as of 28 July 2026$0.24price · delayed$45.9Mmarket cap · indicative
B
Dilution grade
Share count grew 9% in 24 months
Cash runwayno data — not a quarterly (4C/5B) cash filer
Share-count growth (24m)8.7%
Raise cadence (24m)0 cash raises
Options & rights overhang0.0% of shares
In-the-money supply0.0% of shares
Pending proposed issuesnone
COMPUMEDICS LIMITED's ordinary share count was 200M as of November 2025, an increase of 8.7% between July 2024 and November 2025. The company did not raise capital in the 24-month window (0 raises). Options/rights data is not provided. The company does not have a current quarterly cash report on record, so no quarterly cash balance or funding-runway figure is disclosed on that basis. No proposed securities issues (Appendix 3B) are pending.
AI-generated summary of this page's cited filings · updated 28 July 2026
0.0%
Max option dilution
0.0%
ITM option dilution
0
Raises · last 12 months
—
Cash cover · not a quarterly filer
Shares on issue — last 2 years
Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 199.8M per ASX (delayed) (28 July 2026).
Cash runway
Not a quarterly cash filer. This company does not lodge Appendix 4C/5B quarterly cash reports, so cash runway does not apply.
Issuance timeline
Latest 4 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)
| Date | Form | Security | Total on issue after | Source |
|---|---|---|---|---|
| 5 Nov 2025 | 2A · quoted issue | CMP : ORDINARY FULLY PAID | 199.8M | Appendix 2A |
| 20 Jan 2025 | 2A · quoted issue | CMP : ORDINARY FULLY PAID | 192.2M | Appendix 2A |
| 16 Jan 2025 | 2A · quoted issue | CMP : ORDINARY FULLY PAID | 192.0M | Appendix 2A |
| 11 July 2024 | 2A · quoted issue | CMP : ORDINARY FULLY PAID | 183.8M | Appendix 2A |
Paid plan
Full issuance history
Join the waitlist
Capital raises
No equity raises in the last 24 months.
Paid plan
Full raise history
Join the waitlist
Pending proposed issues
No proposed issues (Appendix 3B) currently pending.
Options & convertible securities
No options or rights over unissued shares on record.
Director dealings
No director dealing notices (Appendix 3Y) on record.
Paid plan
Full dealing history
Join the waitlist
Ownership
Free account
Top-20 holders & substantial holder notices
Sign up free — coming soon
Latest announcements
24 Mar 2026March 2026 Corporate Presentation
24 Feb 2026Business Update H1 FY26
30 Oct 2025Initial Director's Interest Notice
30 Oct 2025Results of Meeting
30 Oct 2025Chair's Address to Shareholders
22 Oct 2025Cleansing Notice
20 Oct 2025Canaccord Drug and Device Conference 2025
14 Oct 2025Proposed issue of securities - CMP
8 Oct 2025Corporate Highlights Oct 25
1 Oct 2025Appendix 4G
Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.